-
Infection control professionals in a group of cancer centers have developed an algorithm to help meet new patient safety goals by the Joint Commission on Accreditation of Healthcare Organizations.
-
Word that a portion of the 2004-2005 influenza vaccine will be not available until later in the season poses no immediate health crisis, but underscores the vulnerable nature of vaccine production and distribution in the shadow of a pandemic. Citing sterility problems during the production process, Chiron Corp. in the United Kingdom announced that it would delay delivery of its doses to the United States.
-
The recently released influenza pandemic plan for the United States couldnt be much more timely because there are some pigs on the other side of the world that already may be brewing up the next global outbreak.
-
According to a new draft influenza plan issued by the U.S. Department of Health and Human Services, the following actions must be taken now, before a pandemic strain emerges.
-
-
-
Pipeline or wipeout? The antibiotic era is at risk; Childs play: Finding Bacillus on Barney; Prepare your facility for influenza season.
-
JCAHO lobbies for sign-off on patient safety law; Measles hits record low, imported cases remain; Public comment sought on CDC vaccine safety efforts.
-
Sources of funding for pharmaceutical research has come under scrutiny in the last decade as academic and government sources of funding have become increasingly scarce and the pharmaceutical industry has become the main source of research dollars. But the issue of objectivity has been raised, and some have even suggested that negative studies, that is studies that show a drug in an unfavorable light, may never be published. The American Medical Association has recently tackled this issue and has asked the department of Health and Human Services to establish a public registry of all clinical trials in United States.
-
End-stage renal disease is a devastating condition that, according to the United States Renal Data System, plagued approximately 406,000 individuals in the United States in 2001 and is projected to increase to a prevalence of approximately 725,000 by 2010. Furthermore, it is a major public health issue, given the overall poor outcomes and high costs for this chronic condition.
